The definitive guide to the multidisciplinary specialty of pharmaceutical medicine, encompassing scientific, medical and related activities in the discovery, development, evaluation, registration and monitoring of medicines, the execution of clinical trials, and the regulatory and ethical requirements pertaining to drug development. The journal publishes peer-reviewed original research and review articles covering all aspects of pharmaceutical medicine, from the processes involved in the identification of new active substances, through their development and licensing as medicinal products, to the monitoring of their use in clinical practice.
Pharmaceutical Medicine offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances.The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program
Marjorie A. Speers (March 2019)
- Journal Title
- Pharmaceutical Medicine
- Volume 14 / 2000 - Volume 33 / 2019
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
|International Journal of Pharmaceutical Medicine||1364-9027|
To view the rest of this content please follow the download PDF link above.